Vetoquinol SA (0O1O.L)

EUR 76.5

(0.0%)

Long Term Debt Summary of Vetoquinol SA

Vetoquinol SA's latest annual long term debt in 2023 was 9.66 Million EUR , up 5298.32% from previous year.
Vetoquinol SA's latest quarterly long term debt in 2024 Q2 was 177 Thousand EUR , down 0.0% from previous quarter.
Vetoquinol SA reported annual long term debt of 179 Thousand EUR in 2022, down -4.28% from previous year.
Vetoquinol SA reported annual long term debt of 187 Thousand EUR in 2021, up 6.25% from previous year.
Vetoquinol SA reported quarterly long term debt of 9.66 Million EUR for 2023 Q4, down 0.0% from previous quarter.
Vetoquinol SA reported quarterly long term debt of 9.66 Million EUR for 2023 FY, up 5298.32% from previous quarter.

Annual Long Term Debt Chart of Vetoquinol SA (2023 - 2005)

Historical Annual Long Term Debt of Vetoquinol SA (2023 - 2005)

Year	Long Term Debt	Long Term Debt Growth
2023	9.66 Million EUR	5298.32%
2022	179 Thousand EUR	-4.28%
2021	187 Thousand EUR	6.25%
2020	176 Thousand EUR	-36.46%
2019	277 Thousand EUR	41.33%
2018	196 Thousand EUR	-97.04%
2017	6.63 Million EUR	-57.02%
2016	15.42 Million EUR	-36.15%
2015	24.16 Million EUR	-36.7%
2014	38.17 Million EUR	253.79%
2013	10.78 Million EUR	-50.76%
2012	21.9 Million EUR	34.32%
2011	16.31 Million EUR	0.0%
2010	- EUR	0.0%
2009	- EUR	0.0%
2008	- EUR	0.0%
2007	- EUR	-100.0%
2006	30.19 Million EUR	-13.32%
2005	34.83 Million EUR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	177 Thousand EUR	0.0%
2023 Q4	9.66 Million EUR	0.0%
2023 FY	9.66 Million EUR	5298.32%
2023 Q2	176 Thousand EUR	0.0%
2022 Q4	179 Thousand EUR	0.0%
2022 Q2	190 Thousand EUR	0.0%
2022 FY	179 Thousand EUR	-4.28%
2021 Q2	178 Thousand EUR	0.0%
2021 Q4	187 Thousand EUR	0.0%
2021 FY	187 Thousand EUR	6.25%
2020 Q2	298 Thousand EUR	0.0%
2020 Q4	176 Thousand EUR	0.0%
2020 FY	176 Thousand EUR	-36.46%
2019 FY	277 Thousand EUR	41.33%
2019 Q2	1.18 Million EUR	0.0%
2019 Q4	277 Thousand EUR	0.0%
2018 FY	196 Thousand EUR	-97.04%
2018 Q4	196 Thousand EUR	0.0%
2018 Q2	2.26 Million EUR	0.0%
2017 FY	6.63 Million EUR	-57.02%
2017 Q4	6.63 Million EUR	0.0%
2017 Q2	11.02 Million EUR	0.0%
2016 Q2	20.51 Million EUR	0.0%
2016 FY	15.42 Million EUR	-36.15%
2016 Q4	15.42 Million EUR	0.0%
2015 FY	24.16 Million EUR	-36.7%
2015 Q2	28.44 Million EUR	0.0%
2015 Q4	24.16 Million EUR	0.0%
2014 Q2	42.19 Million EUR	0.0%
2014 FY	38.17 Million EUR	253.79%
2014 Q4	38.17 Million EUR	0.0%
2013 Q4	10.79 Million EUR	0.0%
2013 FY	10.78 Million EUR	-50.76%
2013 Q2	10.8 Million EUR	0.0%
2012 Q4	21.9 Million EUR	0.0%
2012 Q2	- EUR	0.0%
2012 FY	21.9 Million EUR	34.32%
2011 Q4	16.31 Million EUR	0.0%
2011 FY	16.31 Million EUR	0.0%
2010 Q2	20.34 Million EUR	0.0%
2010 Q4	- EUR	0.0%
2010 FY	- EUR	0.0%
2009 Q4	- EUR	0.0%
2009 FY	- EUR	0.0%
2008 FY	- EUR	0.0%
2007 FY	- EUR	-100.0%
2006 FY	30.19 Million EUR	-13.32%
2005 FY	34.83 Million EUR	0.0%

Peer Long Term Debt Comparison of Vetoquinol SA

Name	Long Term Debt	Long Term Debt Difference
Boiron SA	6.64 Million EUR	-45.418%
Laboratorios Farmaceuticos Rovi, S.A.	38.57 Million EUR	74.95%
Valneva SE	132.76 Million EUR	92.722%
AB Science S.A.	16.98 Million EUR	43.119%
Nanobiotix S.A.	41.66 Million EUR	76.805%
PHAXIAM Therapeutics S.A.	7.03 Million EUR	-37.454%
Vivoryon Therapeutics N.V.	- EUR	-Infinity%
BioSenic S.A.	15.57 Million EUR	37.95%
ABIVAX Société Anonyme	44.69 Million EUR	78.381%
Formycon AG	7.81 Million EUR	-23.647%